Vietnam's Pharmaceutical Drug Delivery Market Forecast to Exceed US$12 Million by 2034

Vietnam's expanding pharmaceutical industry, growing chronic disease burden and increasing adoption of advanced medicines are creating new opportunities for technologies that improve how drugs are administered to patients.

According to IMARC Group, the Vietnam Pharmaceutical Drug Delivery Market reached US$7.7 million in 2025 and is forecast to grow to US$12.2 million by 2034, representing a compound annual growth rate of 5.08% between 2026 and 2034.

The market encompasses a broad range of technologies and administration routes, including oral, injectable, topical, ocular, pulmonary, implantable, transmucosal and nasal drug delivery, serving applications from cancer and diabetes to cardiovascular, respiratory, infectious and autoimmune diseases.

A growing pharmaceutical market creates the foundation

The opportunity for drug-delivery technology is developing alongside significant growth in Vietnam's wider pharmaceutical industry.

Fortune Business Insights values the Vietnam pharmaceuticals market at US$8.58 billion in 2025 and forecasts it to reach US$16.03 billion by 2032, representing annual growth of 9.33%.

The country's pharmaceutical market is also becoming more sophisticated. Biologics and biosimilars represented approximately 40.2% of Vietnam's pharmaceutical market in 2024, according to Fortune Business Insights.

This matters for drug delivery because increasingly complex medicines can require equally sophisticated administration technologies.

While conventional tablets remain fundamental, biologics, oncology treatments and other advanced therapies can create demand for pre-filled syringes, auto-injectors, infusion technologies, implantable systems and other specialist delivery platforms.

Chronic diseases drive demand for more effective delivery

Vietnam's changing disease profile represents an important market driver.

An ageing population and increasing prevalence of chronic conditions including diabetes, cardiovascular disease, cancer and respiratory disease are creating greater demand for long-term pharmaceutical treatment.

IMARC identifies the country's expanding elderly population and resulting chronic disease burden as important factors supporting growth of the pharmaceutical drug-delivery market.

For patients requiring treatment over months or years, how a medicine is administered can be almost as important as the medicine itself.

Drug-delivery technologies can potentially improve dosing accuracy, treatment adherence, patient convenience and therapeutic effectiveness, while reducing the need for frequent hospital visits.

Injectable drug delivery becomes increasingly important

Injectable technologies represent a particularly important area of pharmaceutical drug delivery.

The growth of biologics, biosimilars, vaccines and other complex medicines is increasing demand for parenteral administration throughout Asia-Pacific.

MarketsandMarkets identifies injectable drug delivery as the largest route-of-administration segment within the Asia-Pacific pharmaceutical drug delivery market in 2025, driven by increased use of biologics, vaccines and chronic-disease therapies.

For Vietnam, this creates opportunities extending from conventional syringes and vials into pre-filled syringes, auto-injectors, pen injectors, wearable injectors and needle-free technologies.

The commercial ecosystem also extends into components such as pharmaceutical-grade glass, elastomers, needles, closures and specialist packaging.

Self-administration shifts treatment towards the home

One of the most significant developments in drug delivery globally is the movement of appropriate therapies away from hospitals and towards the patient.

Diabetes provides a familiar example through insulin pens and other self-administration devices, but the concept is increasingly being extended to other chronic diseases.

Auto-injectors and pre-filled syringes can enable some medicines that previously required clinical administration to be delivered by patients themselves.

This trend connects directly with the development of home healthcare and patient-centric treatment.

As Vietnam's healthcare system manages rising demand from chronic diseases and an ageing population, technologies that safely move appropriate treatment away from hospitals could become increasingly valuable.

Controlled-release technologies offer another opportunity

Drug delivery is also becoming more sophisticated at the formulation level.

Rather than releasing the entire active ingredient immediately, controlled and sustained-release systems can deliver a medicine over a defined period.

Grand View Research estimates Vietnam's narrower controlled-release drug delivery market at US$0.3 million in 2025, forecasting it to reach US$0.8 million by 2033, representing an 11.8% CAGR.

Although currently a small specialist segment, its projected growth illustrates the direction of travel towards more advanced pharmaceutical-delivery technologies.

Applications include microencapsulation, targeted delivery, implants and transdermal systems.

Targeted delivery could transform treatment

Another important development is the ability to deliver drugs more precisely to the part of the body where they are needed.

This is particularly relevant to oncology.

Conventional systemic treatments can affect both healthy and diseased cells. Targeted delivery technologies aim to concentrate treatment at specific tissues, cells or biological pathways.

Grand View Research identifies targeted delivery as both the largest and fastest-growing technology within Vietnam's controlled-release drug delivery market.

As precision medicine, biologics and advanced cancer therapies develop in Vietnam, the requirement for equally precise delivery mechanisms could increase.

Oral delivery continues to dominate pharmaceutical treatment

Despite rapid innovation in injectable and advanced delivery technologies, oral medicines remain central to Vietnam's pharmaceutical market.

Fortune Business Insights estimates that pharmaceuticals administered orally were worth US$3.82 billion in Vietnam in 2024.

Oral drug delivery is therefore not simply about conventional tablets and capsules.

Innovation increasingly encompasses modified-release formulations, orally disintegrating tablets, protective coatings, microencapsulation and technologies designed to improve the absorption or bioavailability of difficult drug molecules.

For formulation and pharmaceutical technology companies, improving existing oral medicines can represent as important an opportunity as developing entirely new administration routes.

Pulmonary, nasal and transdermal technologies broaden the market

Alternative delivery routes are also becoming more important.

Pulmonary delivery is well established in respiratory medicine through inhalers and nebulisation, while nasal delivery can provide rapid absorption and potentially avoid some of the limitations associated with conventional oral administration.

Transdermal technologies can provide controlled delivery through the skin, potentially improving convenience for medicines requiring sustained administration.

Vietnam's pharmaceutical drug delivery market therefore increasingly spans a spectrum from traditional oral formulations to sophisticated injectable, implantable, inhaled, nasal and transdermal platforms.

Asia-Pacific drug delivery continues to expand

Vietnam's development forms part of a wider regional trend.

MarketsandMarkets values the Asia-Pacific Pharmaceutical Drug Delivery Market at US$457.9 million in 2025, rising to US$479.7 million in 2026 and US$687.9 million by 2031, representing a 7.5% CAGR from 2026–2031.

The regional market is being supported by increasing chronic disease prevalence, greater adoption of biologics, technological advances and expansion of pharmaceutical production.

Injectable delivery currently represents the largest regional segment, while cancer is expected to be among the fastest-growing applications.

An opportunity across the pharmaceutical value chain

For suppliers, pharmaceutical drug delivery extends considerably beyond the finished medicine.

The ecosystem includes formulation technologies, injection systems, auto-injectors, pre-filled syringes, pumps, implants, inhalers, nasal devices, transdermal systems, pharmaceutical packaging, microencapsulation, excipients and specialist manufacturing equipment.

It also connects directly with several rapidly developing areas of Vietnam's pharmaceutical sector, including biologics, biosimilars, oncology, diabetes, vaccines and advanced therapies.

As pharmaceutical products become more complex and treatment increasingly moves towards personalised and patient-centric care, the technology used to deliver those medicines will become increasingly important.

With Vietnam's Pharmaceutical Drug Delivery Market forecast to increase from US$7.7 million in 2025 to US$12.2 million by 2034, the country represents a developing specialist opportunity for pharmaceutical technology, formulation, packaging and delivery-system companies looking to participate in the growth of Vietnam's life-sciences industry.